GlobalData: Osteoporosis market to be $8 bn
China | Analysis | By BioSpectrum Bureau | 0 Comment | 08 Mar, 2013
Singapore: According to GlobalData, the osteoporosis therapeutics market of the US, France, Germany, Italy, Spain, the ...Read more
Quintiles deepens investment in China
China | News | By BioSpectrum Bureau | 0 Comment | 24 Apr, 2012
Singapore, June 18, 2012: CRO leading company, Quintiles plans to establish a Quintiles regional headquarters for China ...Read more
MedImmune and WuXi AppTec Announce Joint Venture to Develop Novel Biologic
China | News | By BioSpectrum Bureau | 0 Comment | 24 Apr, 2012
Singapore: MedImmune, the global biologics arm of AstraZeneca, and WuXi AppTec, a leading research and development outs...Read more
Bal Seal expands in China to tap into growing medical industry
China | News | By BioSpectrum Bureau | 0 Comment | 24 Apr, 2012
Singapore: Responding to predicted growth in China's medical industry, Bal Seal Engineering, a leading provider of cust...Read more
APAC ovarian cancer drug market to grow modestly'
China | Analysis | By BioSpectrum Bureau | 2 Comment | 30 Jan, 2015
Singapore: Asia Pacific (APAC) therapeutics market for ovarian cancer will undergo a modest rise in value, from $294.3 m...Read more
China Botanic reports Q3 2012 results
China | Company results | By BioSpectrum Bureau | 0 Comment | 21 Sep, 2012
Singapore: China Botanic Pharmaceutical revealed its financial results for the three months ending July 31, 2012. During...Read more
Golden Meditech Acquires Convertible Notes to Increase Stake in Hospital Management Business
China | News | By BioSpectrum Bureau | 0 Comment | 24 Apr, 2012
Singapore: Golden Meditech Holdings, together with its subsidiaries, a leading integrated healthcare enterprise in Chin...Read more
Research and Markets offers new report on China pharma industry
China | News | By BioSpectrum Bureau | 0 Comment | 14 May, 2012
Singapore: Research and Markets has added a report on China Pharmaceutical Machinery Industry to their offering. This r...Read more
China Biologics appoint David Gao to additional post of CEO
China | News | By BioSpectrum Bureau | 0 Comment | 24 Apr, 2012
China Biologic Products, one of the leading plasma-based biopharmaceutical companies in the People's Republic of China,...Read more
BMS pledges $15 million to help curb diabetes in India and China
China | News | By BioSpectrum Bureau | 0 Comment | 24 Apr, 2012
Singapore: The Bristol-Myers Squibb Foundation has expanded its Together on Diabetes initiative to China and India, pled...Read more
Genetic diagnostics companies speed ahead
China | Opinion | By Nandita Singh | 0 Comment | 28 Jun, 2013
The playing field for research and development for genetic diagnostics has been leveled. The landmark decision by the US...Read more
Bristol-Myers Squibb reveals new grants for Hepatitis in India, China
China | News | By BioSpectrum Bureau | 0 Comment | 24 Apr, 2012
Singapore, July 30, 2012: The Bristol-Myers Squibb Foundation has awarded four new grants totaling US $1.69 million to i...Read more
Tiyanyin pharma all set for GMP inspection
China | Regulatory | By BioSpectrum Bureau | 4 Comment | 15 Jul, 2014
Singapore: China-based Tianyin Pharmaceutical is looking ahead to get its Qionglai Facility (QLF) GMP certified post ins...Read more
Industry applauds Dr Weidong Yin
China | Influencers | By BioSpectrum Bureau | 0 Comment | 15 Mar, 2012
"I met Dr Weidong Yin for the first time in 1996 when I went to Tangshan, China. At that time, he was involved in resear...Read more
Simcere, Zhuhai enter share transfer agreement
China | News | By BioSpectrum Bureau | 0 Comment | 26 Jun, 2013
Singapore: Leading pharmaceutical company, Simcere Pharmaceutical, announced sale of equity interest in Jilin Bodapharma...Read more
SFDA reports high chromium in Biostar's drug
China | Regulatory | By BioSpectrum Bureau | 1 Comment | 24 Apr, 2012
Singapore, June 01, 2012: China based Biostar Pharmaceuticals has acknowledged the finding of chromium content higher ...Read more
US biotech firm invests in China to enter Asia
China | News | By BioSpectrum Bureau | 0 Comment | 24 Apr, 2012
Singapore, June 01, 2012: GenScript, a US biotech company, has announced the opening of a new R&D facility in Nanjin...Read more
Ambrx, Zhejiang, WuXi to develop cancer drug in China
China | News | By BioSpectrum Bureau | 0 Comment | 17 Jun, 2013
Singapore: US-based Ambrx and China-based Zhejiang Medicine (ZMC) announced that they have formed a collaboration to dev...Read more